Vident Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Vident Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.88M	Buy	9,740 +1,127	+13%	+$541K	0.04%	410
2026 Q1	$4.23M	Buy	8,613 +2,652	+44%	+$1.44M	0.04%	399
2025 Q4	$3.45M	Buy	5,961 +373	+7%	+$211K	0.03%	417
2025 Q3	$2.71M	Buy	5,588 +588	+12%	+$274K	0.03%	468
2025 Q2	$2.03M	Sell	5,000 -738	-13%	-$309K	0.02%	497
2025 Q1	$2.86M	Buy	5,738 +1,092	+24%	+$591K	0.04%	366
2024 Q4	$2.42M	Sell	4,646 -11	-0.2%	-$6.05K	0.04%	370
2024 Q3	$2.88M	Buy	4,657 +1,083	+30%	+$641K	0.07%	298
2024 Q2	$1.98M	Buy	3,574 +408	+13%	+$234K	0.05%	376
2024 Q1	$1.84M	Buy	3,166 +166	+6%	+$93.1K	0.04%	392
2023 Q4	$1.59M	Sell	3,000 -86	-3%	-$41.6K	0.04%	434
2023 Q3	$1.56M	Buy	+3,086	New	+$1.64M	0.05%	377

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vident Advisory's TMO Position: Q2 2026 in Review

Vident Advisory increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $541K and bringing the position to 9,740 shares worth $4.88M. The position accounts for 0.04% of the portfolio, ranked #410.

Vident Advisory first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Vident Advisory held 9,740 shares of Thermo Fisher Scientific worth $4.88M as of Q2 2026.
Vident Advisory bought 1,127 Thermo Fisher Scientific shares in Q2 2026, an estimated $541K.
Thermo Fisher Scientific made up 0.04% of Vident Advisory's portfolio in Q2 2026, its #410 holding.
Vident Advisory first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.